Colgate-Palmolive Company $CL Shares Acquired by Ashurst Perkins Coie Trust Co

Ashurst Perkins Coie Trust Co lifted its holdings in Colgate-Palmolive Company (NYSE:CL) by 3,677.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,983 shares of the company’s stock after purchasing an additional 19,454 shares during the quarter. Ashurst Perkins Coie Trust Co’s holdings in Colgate-Palmolive were worth $1,705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in CL. Corient Private Wealth LP boosted its holdings in Colgate-Palmolive by 29.0% in the second quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock worth $58,639,000 after purchasing an additional 143,812 shares during the last quarter. Bank of America Corp DE bought a new stake in Colgate-Palmolive in the 2nd quarter worth approximately $567,483,000. Brandywine Financial Group increased its position in Colgate-Palmolive by 35,612.3% during the first quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock valued at $6,209,000 after acquiring an additional 72,649 shares during the last quarter. SEB Asset Management AB bought a new position in Colgate-Palmolive in the first quarter valued at about $91,149,000. Finally, Robinhood Asset Management LLC bought a new position in Colgate-Palmolive in the second quarter valued at about $11,554,000. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director John Cahill sold 4,170 shares of the stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00. Following the sale, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Up 3.2%

CL stock opened at $92.80 on Thursday. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The stock has a market cap of $73.98 billion, a P/E ratio of 36.83, a PEG ratio of 4.30 and a beta of 0.33. The business’s 50-day moving average price is $89.04 and its 200-day moving average price is $88.93.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same period in the prior year, the firm posted $0.92 EPS. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is 84.13%.

Analysts Set New Price Targets

CL has been the subject of several research reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Barclays raised their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Morgan Stanley restated an “overweight” rating and set a $104.00 target price (up from $100.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Weiss Ratings cut shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Finally, BNP Paribas Exane decreased their price target on shares of Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, September 28th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $98.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.